Trials / Completed
CompletedNCT00940667
Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension
A Phase III, 8-week, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Amlodipine 5mg+Losartan 50mg Versus Amlodipine 10mg in Patients With Essential Hypertension Not Controlled on Amlodipine Monotherapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 185 (actual)
- Sponsor
- Hanmi Pharmaceutical Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate of efficacy and safety of amlodipine plus losartan and amlodipine alone in patients with essential hypertension inadequately controlled on amlodipine monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amlodipine plus Losartan | amlodipine/losartan 5/50mg q.d. |
| DRUG | Amlodipine | amlodipine 5mg q.d. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-07-16
- Last updated
- 2016-10-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00940667. Inclusion in this directory is not an endorsement.